受取配当金、Transfer Of Negative Balance In Other Capital SurplusIFRS、セグメント資産 - 医薬品
- 【期間】
| 年度 | 受取配当金 | Transfer Of Negative Balance In Other Capital SurplusIFRS | セグメント資産 - 医薬品 |
|---|
| 2008/03 | 69.2億 | | - | | - | |
| 2009/03 | 67.9億 | -1.9% | - | | - | |
| 2010/03 | 48.5億 | -28.5% | - | | - | |
| 2011/03 | 47.1億 | -3% | - | | - | |
| 2012/03 | 58.8億 | +24.8% | - | | - | |
| 2013/03 | 55.9億 | -4.8% | - | | - | |
| 2014/03 | 60.5億 | +8.1% | - | | - | |
| 2015/03 | 115億 | +90.8% | - | | - | |
| 2016/03 | 61.4億 | -46.8% | - | | - | |
| 2017/03 | 57.4億 | -6.5% | - | | - | |
| 2018/03 | - | | - | | 0.87兆 | |
| 2019/03 | - | | - | | 0.9兆 | +3.1% |
| 2020/03 | - | | - | | 1.31兆 | +46.4% |
| 2021/03 | - | | - | | 1.36兆 | +3.9% |
| 2022/03 | - | | - | | 1.37兆 | +0.2% |
| 2023/03 | - | | - | | 1.19兆 | -13% |
